---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-273442"
form_type: "8-K"
ticker: "CME"
cik: "0001156375"
company_name: "CME GROUP INC."
filed_at: "2026-06-17T12:35:53+00:00"
generated_at: "2026-06-17T12:40:49.214320+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CME Group CEO Terry Duffy to transition to Executive Chairman in March 2027; President & CFO Lynne Fitzpatrick named CEO

## Summary
- Terrence A. Duffy will become Executive Chairman effective March 1, 2027 (or later when 2026 10-K is filed); he remains CEO until then.
- Lynne C. Fitzpatrick, currently President and CFO, will succeed Duffy as CEO and join the Board on the transition date.
- Fitzpatrick's CEO compensation: $1.2M base salary; annual bonus target 200% of base; LTI target 700% of base.
- Company will conduct a search for a successor to Fitzpatrick as CFO.
- Duffy's transition agreement provides continued base salary, bonus and equity vesting at target through his Executive Chairman term ending Dec 31, 2027.

## SEC filing metadata
- accession: 0001193125-26-273442
- form_type: 8-K
- ticker: CME
- cik: 0001156375
- company_name: CME GROUP INC.
- filed_at: 2026-06-17T12:35:53+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156375/000119312526273442/0001193125-26-273442-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156375/000119312526273442/d129556d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-273442
- JSON: https://secwatch.observer/filing/0001193125-26-273442.json
- Plain text: https://secwatch.observer/filing/0001193125-26-273442.txt

## Key facts
- Executive change
  Lynne C. Fitzpatrick was appointed as Director at CME GROUP INC..
  - Action: appointed
  - Role: Director
  source text: Ms. Fitzpatrick will continue to serve as the Company’s President and Chief Financial Officer through the Transition Date and will then assume the role of Chief Executive Officer and be appointed to the Board and its Executive Committee on the Transition Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1156375/000119312526273442/0001193125-26-273442-index.htm
- Executive change
  Lynne C. Fitzpatrick changed role as Chief Executive Officer at CME GROUP INC..
  - Action: succeed
  - Role: Chief Executive Officer
  source text: Lynne C. Fitzpatrick, the Company’s current President and Chief Financial Officer, will succeed Mr. Duffy as the Company’s Chief Executive Officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/1156375/000119312526273442/0001193125-26-273442-index.htm
- Executive change
  Terrence A. Duffy was appointed as Executive Chairman at CME GROUP INC..
  - Action: appointed
  - Role: Executive Chairman
  source text: Terrence A. Duffy, the Company’s current Chairman and Chief Executive Officer, will become the Company’s Executive Chairman
  evidence_url: https://www.sec.gov/Archives/edgar/data/1156375/000119312526273442/0001193125-26-273442-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.